全球治療診斷學市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計治療診斷學市場將從 2025 年的 34 億美元成長到 2034 年的 111.5 億美元，2026 年至 2034 年的複合年成長率為 14.11%。

隨著個人化醫療在現代醫療保健中日益重要，全球治療診斷學市場正迅速成長。治療診斷學結合了治療和診斷技術，能夠同時識別疾病並提供標靶治療。這種方法使醫療專業人員能夠更準確地診斷病情，並為每位患者量身定做治療方案，從而改善治療效果並減少副作用。

市場的主要促進因素之一是癌症和心血管疾病等慢性病的盛行率上升。治療診斷學在腫瘤學中發揮著至關重要的作用，它能夠實現腫瘤的早期檢測和標靶藥物傳遞。分子影像學、核子醫學和生物標記研究的進步也為多種疾病的創新治療診斷學解決方案的開發提供了支持。

隨著醫療保健系統向精準醫療轉型，治療診斷學市場預計將顯著成長。製藥和生技公司正大力投資研發，以開發新型治療診斷學藥物和診斷工具。未來幾年，醫療保健領域投入的增加以及人們對個人化治療方案日益成長的認知，將繼續推動治療診斷學的應用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球治療診斷學市場：依產品分類

• 市場分析、洞察與預測
• 診斷影像
• 放射性藥物
• 體外診斷/生物標記篩檢
• 軟體和服務

第5章 全球治療診斷學市場：依應用領域分類

• 市場分析、洞察與預測
• 攝護腺癌
• 骨轉移
• 神經內分泌腫瘤
• 淋巴瘤
• 心血管疾病
• 其他

第6章：全球治療診斷學市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 診斷中心
• 專科診所
• 其他

第7章 全球治療診斷學市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Bayer AG
  • Beckman Coulter Inc
  • Cardinal Health Inc
  • Canon Medical Systems Corporation
  • Curium
  • F. Hoffmann La Roche Ltd
  • GE HealthCare Technologies Inc
  • Koninklijke Philips NV
  • Lantheus Holdings Inc
  • Siemens Healthnieers AG
  • Thermo Fisher Scientific Inc

The Theranostics Market size is expected to reach USD 11.15 Billion in 2034 from USD 3.40 Billion (2025) growing at a CAGR of 14.11% during 2026-2034.

The global theranostics market is growing rapidly as personalized medicine becomes increasingly important in modern healthcare. Theranostics combines therapeutic and diagnostic technologies to identify diseases and deliver targeted treatments simultaneously. This approach allows healthcare professionals to diagnose conditions more accurately and tailor treatments to individual patients, improving treatment outcomes and reducing side effects.

One of the major drivers of the market is the rising prevalence of chronic diseases such as cancer and cardiovascular disorders. Theranostics plays a significant role in oncology by enabling early detection of tumors and targeted drug delivery. Advances in molecular imaging, nuclear medicine, and biomarker research are also supporting the development of innovative theranostic solutions for various medical conditions.

Looking ahead, the theranostics market is expected to grow significantly as healthcare systems move toward precision medicine. Pharmaceutical and biotechnology companies are investing heavily in research and development to create new theranostic drugs and diagnostic tools. Increasing healthcare investments and growing awareness about personalized treatment approaches will continue to drive the adoption of theranostics in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Diagnostic Imaging
• Radiopharmaceuticals
• IVD/Biomarker Screeening
• Software And Services

By Application

• Prostate Cancer
• Bone Metastasis
• Neuroendocrine Tumors
• Lymphoma
• Cardiovascular Diseases
• Other

By End-Use

• Hospitals
• Diagnostics Centers
• Specialty Clinics
• Other

COMPANIES PROFILED

• Bayer AG, Beckman Coulter Inc, Cardinal Health Inc, Canon Medical Systems Corporation, Curium, F Hoffmann La Roche Ltd, GE HealthCare Technologies Inc, Koninklijke Philips NV, Lantheus Holdings Inc, Siemens Healthnieers AG, Thermo Fisher Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL THERANOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Diagnostic Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Radiopharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. IVD/Biomarker Screeening Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Software And Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL THERANOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Bone Metastasis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Neuroendocrine Tumors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Lymphoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL THERANOSTICS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostics Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL THERANOSTICS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL THERANOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Bayer AG
  • 9.2.2 Beckman Coulter Inc
  • 9.2.3 Cardinal Health Inc
  • 9.2.4 Canon Medical Systems Corporation
  • 9.2.5 Curium
  • 9.2.6 F. Hoffmann La Roche Ltd
  • 9.2.7 GE HealthCare Technologies Inc
  • 9.2.8 Koninklijke Philips N.V
  • 9.2.9 Lantheus Holdings Inc
  • 9.2.10 Siemens Healthnieers AG
  • 9.2.11 Thermo Fisher Scientific Inc